NCT00283348

Brief Summary

The purpose of this study is to help researchers find out more about a condition called "Chronic Allograft Nephropathy" (CAN). CAN is a complication that sometimes occurs after kidney transplantation and affects the function of the transplanted kidney. It is hoped that by studying blood, urine, and tissue samples of kidney transplant patients, new ways of diagnosing and treating CAN may be found.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
121

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2006

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2006

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

January 25, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 27, 2006

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2008

Completed
Last Updated

March 20, 2017

Status Verified

March 1, 2017

Enrollment Period

2.9 years

First QC Date

January 25, 2006

Last Update Submit

March 16, 2017

Conditions

Chronic Rejection

Keywords

Renal TransplantationImmunosuppressionChronic Rejection

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients Diagnosis of Chronic Allograft Nephropathy at VCUHS Clinic

You may qualify if:

  • Received primary kidney transplant Diagnosis of Chronic Allograft Nephropathy Stable immunosuppression for one month prior to entry

You may not qualify if:

  • Serious comorbidity Pregnancy Retransplantation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VCU Health System

Richmond, Virginia, 23298, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

Blood, Urine

Study Officials

  • Daniel G Maluf, MD

    Virginia Commonwealth University

    PRINCIPAL INVESTIGATOR

  • Valeria Mas, Ph.D.

    Virginia Commonwealth University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 25, 2006

First Posted

January 27, 2006

Study Start

January 1, 2006

Primary Completion

December 1, 2008

Study Completion

December 1, 2008

Last Updated

March 20, 2017

Record last verified: 2017-03

Locations

US(1)